Your browser doesn't support javascript.
loading
Optimization of amide-based EP3 receptor antagonists.
Lee, Esther C Y; Futatsugi, Kentaro; Arcari, Joel T; Bahnck, Kevin; Coffey, Steven B; Derksen, David R; Kalgutkar, Amit S; Loria, Paula M; Sharma, Raman.
Afiliação
  • Lee EC; Worldwide Medicinal Chemistry, Pfizer Worldwide Research & Development, Cambridge, MA 02139, United States. Electronic address: esther.lee2@pfizer.com.
  • Futatsugi K; Worldwide Medicinal Chemistry, Pfizer Worldwide Research & Development, Cambridge, MA 02139, United States.
  • Arcari JT; Worldwide Medicinal Chemistry, Pfizer Worldwide Research & Development, Groton, CT 06340, United States.
  • Bahnck K; Worldwide Medicinal Chemistry, Pfizer Worldwide Research & Development, Groton, CT 06340, United States.
  • Coffey SB; Worldwide Medicinal Chemistry, Pfizer Worldwide Research & Development, Groton, CT 06340, United States.
  • Derksen DR; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research & Development, Groton, CT 06340, United States.
  • Kalgutkar AS; Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research & Development, Cambridge, MA 02139, United States.
  • Loria PM; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research & Development, Groton, CT 06340, United States.
  • Sharma R; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research & Development, Groton, CT 06340, United States.
Bioorg Med Chem Lett ; 26(11): 2670-5, 2016 06 01.
Article em En | MEDLINE | ID: mdl-27107947

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Prostaglandina E Subtipo EP3 / Amidas Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Prostaglandina E Subtipo EP3 / Amidas Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article